CBD is gaining popularity as a remedy for pregnancy symptoms like nausea and anxiety, but new research suggests it may not be as safe as many believe.
A study from McMaster University found that oral cannabis use, including both THC and CBD, is linked to impaired fetal growth, abnormal placental development, and long-term behavioral changes in offspring.
CBD Use in Pregnancy: Research Uncovers Potential Risks
Cannabidiol (CBD), a compound in cannabis often used for therapeutic purposes, is becoming increasingly popular among pregnant individuals to help manage symptoms like nausea, anxiety, and sleep disturbances. While many believe that CBD — especially when taken orally — is a safer option, research on its effects during pregnancy remains limited.
A new study from researchers at McMaster University sheds light on this knowledge gap, revealing potential risks linked to both CBD and tetrahydrocannabinol (THC), the psychoactive component of cannabis. The findings suggest that using these substances during pregnancy may impair fetal growth and development.
Published today (February 5, 2025) in eBioMedicine, part of The Lancet Discovery Science, the study found that oral cannabis use from early to mid-pregnancy was associated with restricted fetal growth, changes in placental development, and long-term effects on offspring behavior, including altered aggression, activity levels, and learning ability.
Perception vs. Reality: Is CBD Really Safe?
"The use of cannabis during pregnancy is rising in Canada. Most previous studies focus on exposure to cannabis smoke or just the psychoactive component of cannabis (THC), leaving other cannabis ingredients and methods of consumption understudied. However, consuming cannabis orally or only using other cannabis ingredients like CBD, is often perceived as safer despite this lack of evidence. Our study is shedding light that there's a possibility that CBD might also be harmful in the pregnancy," says Tyrah Ritchie, who led the study while completing her master's degree in the Medical Sciences program at McMaster University and with the McMaster Immunology Research Centre.
Cannabis Use May Impact Growth and Behavior
The group of scientists led by Ritchie and Ali Ashkar, professor with McMaster's Department of Medicine, conducted the research by administering cannabis oil to mouse models and followed the development of the fetuses during pregnancy and post-birth.
The researchers found that both THC and CBD impaired fetal growth causing fetuses to be small when compared to mice that did not receive cannabis. Additionally, they found that both THC and CBD impact the development of the blood vessels that supply the placenta and therefore the baby with nutrients.
"We did see that both THC and CBD can disrupt a special type of immune cell called a Uterine NK Cell that is crucial in normal development of the placenta. We also saw poor development of the arteries that help supply blood to the placenta. We're thinking this is what is possibly disrupting the nutrient and oxygen delivery to the baby and contributing to the intrauterine growth restriction," says Ashkar.
Long-Term Effects on Offspring Behaviour
When observing the behavior of the babies post-birth, researchers found changes in their aggression, activity levels, and even learning ability.
"Oral use of THC and CBD during the pregnancy not only disrupts the growth of the baby but seems to have long-term consequences as the babies were found to have changes in their behavior later in life," says Ritchie.
More Research Needed on CBD and Pregnancy
Ritchie says more research is needed to better understand the impacts of cannabis in humans during pregnancy, but says this study shows the possibility of it being dangerous or harmful.
Reference: "The impact of oral cannabis consumption during pregnancy on maternal spiral artery remodelling, fetal growth and offspring behaviour in mice" by Tyrah M. Ritchie, Emily Feng, Fatemeh Vahedi, Sofya Ermolina, Christian J. Bellissimo, Erica De Jong, Ana L. Portillo, Sophie M. Poznanski, Lauren Chan, Sara M. Ettehadieh, Deborah M. Sloboda, Dawn M.E. Bowdish and Ali A. Ashkar, 5 February 2025, eBioMedicine.
DOI: 10.1016/j.ebiom.2025.105572
Funding for the study was provided by The Michael G. DeGroote Centre for Medicinal Cancer Research, the Canadian Institutes of Health Research, and the Canadian Foundation for Innovation.
News
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
